ADMA Biologics Inc
Panjang

ADMA (ADMA Biologics Inc.) โ€“ 30-Min Long Trade Setup!

37
๐Ÿš€
๐Ÿ”น Asset: ADMA โ€“ NASDAQ
๐Ÿ”น Timeframe: 30-Min Chart
๐Ÿ”น Setup Type: Bullish Breakout (Rising Wedge & Fibonacci Confluence)

๐Ÿ“Š Trade Plan (Long Position)
โœ… Entry Zone: Above $20.60 (Breakout Confirmation)
โœ… Stop-Loss (SL): Below $19.75 (Key Support Level)

๐ŸŽฏ Take Profit Targets
๐Ÿ“Œ TP1: $21.68 (Resistance Level)
๐Ÿ“Œ TP2: $23.20 (Extended Bullish Move)

๐Ÿ“Š Risk-Reward Ratio Calculation
๐Ÿ“‰ Risk (SL Distance):
$20.60 - $19.75 = $0.85 risk per share

๐Ÿ“ˆ Reward to TP1:
$21.68 - $20.60 = $1.08 (1:1.27 R/R)

๐Ÿ“ˆ Reward to TP2:
$23.20 - $20.60 = $2.60 (1:3.05 R/R)

โœ… Favorable Risk-Reward Ratio toward TP2

๐Ÿ” Technical Analysis & Strategy
๐Ÿ“Œ Rising Wedge Breakout: Price action is holding above key levels, signaling bullish momentum.
๐Ÿ“Œ Fibonacci Confluence: The 0.382, 0.5, and 0.618 retracement levels provide strong support.
๐Ÿ“Œ Volume Confirmation Needed: Look for above-average buying volume above $20.60 to validate the breakout.
๐Ÿ“Œ Resistance at $21.68: A breakout above this will strengthen the bullish move toward TP2.

๐Ÿ“‰ Trade Execution & Risk Management
๐Ÿ“Š Volume Confirmation: Ensure strong buying volume above $20.60 before entering.
๐Ÿ“‰ Trailing Stop Strategy: Move SL to break-even ($20.60) after hitting TP1 ($21.68).

๐Ÿ’ฐ Partial Profit Booking Strategy
โœ” Take 50% profits at TP1 ($21.68), let the rest run toward TP2 ($23.20).
โœ” Adjust Stop-Loss to Break-even ($20.60) after TP1 is reached.

โš ๏ธ Risks & Considerations
โŒ Fake Breakout Risk: If the price fails to hold above $20.60, exit early.
โŒ Confirmation Required: Wait for a 30-min candle close above $20.60 before entering.

๐Ÿš€ Final Thoughts
โœ” Bullish Setup โ€“ Strong upside potential.
โœ” Momentum Shift Possible โ€“ Watch for volume confirmation.
โœ” Favorable Risk-Reward Ratio โ€“ 1:3.05 toward TP2.

๐Ÿ’ก Stick to the plan, manage risk, and trade smart! ๐Ÿš€๐Ÿ“ˆ
๐Ÿ”— #ADMA #NASDAQ #LongTrade #TradingView #ProfittoPath ๐Ÿ’ฐ๐Ÿ“Š

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.